Schedule 13G ownership disclosure
DECIPHERA PHARMACEUTICALS IN
Security class unavailable · CUSIP: 24344T101
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,836,159
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000769993-23-000117
- Form type
- SC 13G
- Filer
- Deciphera Pharmaceuticals, Inc.
- CIK
- CIK 1654151
- Filed
- Feb 08, 2023
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership